-
Loading metrics
Open Access
Peer-reviewed
Research Article
Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors
-
Eun Hye Oh,
Affiliation Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Kyunghwan Oh,
Affiliation Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Minkyu Han,
Affiliation Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul, Korea
⨯ -
Hyungil Seo,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Kiju Chang,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Sun-Ho Lee,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Gwang-Un Kim,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Eun Mi Song,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Myeongsook Seo,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Ho-Su Lee,
Affiliation Health Screening and Promotion Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Sung Wook Hwang,
Affiliations Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Sang Hyoung Park,
Affiliations Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Dong-Hoon Yang,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Kyung-Jo Kim,
Affiliations Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Jeong-Sik Byeon,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Seung-Jae Myung,
Affiliation Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ -
Suk-Kyun Yang,
Affiliations Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ - [ ... ],
-
Byong Duk Ye
* E-mail: bdye@amc.seoul.kr
Affiliations Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Inflammatory Bowel Disease Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
⨯ - [ view all ]
- [ view less ]
Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors
- Eun Hye Oh,
- Kyunghwan Oh,
- Minkyu Han,
- Hyungil Seo,
- Kiju Chang,
- Sun-Ho Lee,
- Gwang-Un Kim,
- Eun Mi Song,
- Myeongsook Seo,
- Ho-Su Lee
- Published: May 23, 2017
- https://doi.org/10.1371/journal.pone.0177479